Skip to main content

Vident Advisory, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1744347 Alpharetta, GA

Position in NBIX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,249,670
+$1,986,586 QoQ
Shares Held
13,348
+568.4% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#301
of 768 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority Sole 14% Shared 0% None 86%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Vident Advisory, LLC holds $34,283,611 across 24 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (6.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NBIX
Neurocrine Biosciences Inc
This page
13,348 $2,249,670

All Filings in NBIX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,249,670 13,348
2026-03-31 $263,084 1,997
2025-12-31 $231,324 1,631
2025-09-30 $259,982 1,852
2025-06-30 $236,421 1,881
2025-03-31 $201,733 1,824
2024-06-30 $359,730 2,613
2024-03-31 $13,482,230 97,754
2023-12-31 $334,010 2,535
2023-09-30 $302,287 2,687